Objectives: To determine the location of the antibiotic resistance genes in the MDR Proteus mirabilis PmPHI clinical isolate.
Introduction
Proteus mirabilis is an opportunistic human pathogen that is generally susceptible to all classes of antibiotic agents active against Gram-negative bacilli, with the exception of tetracyclines and polymyxins. Antibiotic resistance is often due to the acquisition of resistance genes associated with integrons, transposons or ISs. 1 Class 1 and class 2 integrons are those most frequently encountered in P. mirabilis. 2, 3 The former are generally plasmid-borne and the latter are found on transposon Tn7 mainly inserted into the chromosomal glmS transcriptional terminator. 4, 5 Sometimes the resistance genes are clustered into structures named genomic islands (GIs). Several types of GIs have been described to date. The most frequently encountered in P. mirabilis are Salmonella genomic island 1 (SGI1) [6] [7] [8] and Proteus genomic island 1 (PGI1) 9, 10 , belonging to the same superfamily of GIs that also includes SGI2 and AGI1, identified in Acinetobacter baumannii.
11 SGI1, initially found in Salmonella enterica serovars, and PGI1 are large integrative mobilizable elements. 12, 13 They target the last 18 bp of the chromosomal trmE gene, encode related integrases and consist of a backbone and an MDR region located adjacent to the res gene. Different variants with backbone alterations and/or MDR region variations have been described. 14 Besides these GIs, SXT/R391-related integrative conjugative elements (ICEs) have been described in P. mirabilis. 15, 16 These large elements, originally discovered in Vibrio cholerae (SXT) or Providencia rettgeri (R391), are integrated into the peptide chain release factor 3 gene (prfC). 17 Various genes have been identified in hot spots (HS1-HS5) and variable regions (VRI-VRIV) of ICEs. Genetic diversity of these ICEs has been reported in MDR P. mirabilis in China. 18 During our continuous survey of SGI1 and PGI1 among MDR P. mirabilis, we used PCRs with primers targeting the ORF S026 and the left and right junctions of these GIs. 8 The isolate PmPHI, lacking the ORF S026 and with an undetectable intact trmE, was retained for characterization of its resistance genes content and their genetic context using WGS. 
Materials and methods

Bacterial strain
P. mirabilis PmPHI was isolated in August 2012 from a patient hospitalized in the haematology ward of Dijon hospital (France). Antibiotic susceptibility testing performed by the disc diffusion method according to the Antibiogram Committee of the French Society for Microbiology (CASFM)/ EUCAST guidelines included: (i) b-lactams (amoxicillin, amoxicillin/clavulanic acid, ticarcillin, imipenem, cefalotin, cefoxitin, cefotaxime and ceftazidime); (ii) aminoglycosides (streptomycin, spectinomycin, kanamycin, gentamicin, tobramycin and amikacin); (iii) phenicols (chloramphenicol); (iv) tetracyclines (doxycycline); (v) folate inhibitors (sulfamethoxazole and trimethoprim); (vi) quinolones (nalidixic acid and ciprofloxacin); and (vii) rifampicin.
DNA sequencing
Genomic DNA was extracted using the DNeasy blood and tissue kit (QIAGEN). Class 1 integrons (sul1-type with primers L1-R1 and Tn402-type with L1-RH506) and class 2 integrons were searched and sequenced by the Sanger method. 19 The whole genome was sequenced with an Illumina MiSeq sequencer using the Nextera XT DNA sample preparation kit, according to the manufacturer's instructions. De novo assembly was performed with Velvet from the galaxy.prabi.fr web service (http://galaxy.prabi.fr/). All contigs were searched for resistance genes and potential foreign genetic structures using BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi). PCR linkage between genes belonging to non-repeated genetic elements and Sanger sequencing were performed to fill the gap between contigs of interest. The Illumina reads were mapped on the assembled sequences using the BWA (BurrowsWheeler Aligner) read aligner (Galaxy) and visualized with the Integrative Genomics Viewer (IGV) (Broad Institute, http://software.broadinstitute.org/ software/igv/) to identify potential base mismatches.
Conjugation experiments and mobilization assays
Conjugation experiments were carried out by a broth mating method using the rifampicin-resistant Escherichia coli K-12 C600 recipient strain. Transconjugants were selected on sorbitol MacConkey agar supplemented with rifampicin (50 mg/L) and gentamicin (4 mg/L) (for the transfer of GIPmi1) or with rifampicin (50 mg/L) and chloramphenicol (50 mg/L) (for the transfer of ICEPmiFra1). When transfer failed, mobilization assays were carried out using Enterobacter aerogenes 409 harbouring an A/C 2 plasmid (pEA409TEM24 GenBank accession number MG764534) or its E. coli K-12 C600 transconjugant, as previously described, to mobilize SGI1 and PGI1. 13 
Nucleotide sequence accession number
The nucleotide sequences of GIPmi1, ICEPmiFra1 and Tn7 were assigned GenBank accession numbers MF490433, MF490434 and MG701057, respectively. The Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number PUXR00000000. The version described in this article is version PUXR01000000.
Results and discussion
Antibiotic susceptibility, integron content and genome analysis P. mirabilis PmPHI was resistant to: amoxicillin and ticarcillin; streptomycin, spectinomycin, kanamycin, gentamicin and tobramycin; chloramphenicol; doxycycline; sulfamethoxazole and trimethoprim; nalidixic acid and ciprofloxacin.
Various cassette arrays were detected on two sul1-type class 1 integrons (aadB-aadA2 and dfrA32-ereA1-aadA2), one Tn402-type class 1 integron (estX-qacE), and one class 2 integron (dfrA1-sat2-aadA1).
Genome analysis revealed that these integrons were embedded in three acquired genetic structures. The first one was a GI named GIPmi1 inserted at the 3 0 end of trmE. The second one was an ICE named ICEPmiFra1 inserted within prfC. The last one was a Tn7 located downstream of glmS. Resistance to quinolones was due to the well-known mutations in the quinolone resistancedetermining regions of gyrA (S83I) and parC (S84I). No plasmids were found.
Characterization of GIPmi1
The 55.8 kb GI, GIPmi1, consisted of a backbone and an MDR region. Its backbone shared 93% identity with a structure detected in Enterobacter cloacae complex 'Hoffmann cluster IV' strain DSM 16690 (accession number CP017184). Both structures were inserted by site-specific recombination into the last 18 bp of trmE, as for SGI1 and PGI1. Unlike the GI from E. cloacae, GIPmi1 carried an MDR region close to a resolvase gene. The backbone of the GI (18.7 kb) contained 14 ORFs with a GC content equal to 43.5% (Figure 1a ). The integrase gene was similar to those of SGI1, SGI2, PGI1 and AGI1 (64%-67% DNA identity). A higher similarity was found with other integrase genes: 95% identity with that of E. cloacae DSM 16690, 93% and 92% with an integrase gene found at the end of trmE in Shewanella putrefaciens 200 (CP002457) and S. putrefaciens CN-32 (CP000681), respectively; 98% with a partial integrase gene in S. enterica subsp. enterica serovar Senftenberg strain ATCC 43845 (CP019194). The resolvase gene and the nucleotide sequence of the three ORFs of unknown function at the right end of GIPmi1 shared 92%-99% identity with those found in these four strains. Other ORFs encoded products of putative function: a transcriptional regulator of the excisionase family, a helicase, a hydroxy acid dehydrogenase (virulence protein of the RhuM family), a DNA methyltransferase, an ATP-binding protein and a DEAD/DEAH-box helicase (ORFs RI02, RI03, RI05, RI08, RI09 and RI10, respectively). No reading frames encoding proteins with possible conjugative functions were found.
The complex MDR region (37.1 kb) was flanked by a 5 bp duplication of the target sequence (CTGGT), as generated by insertion via transposition (Figure 1b) . It was composed of two class 1 integrons separated by a structure of 22.9 kb. The Tn402-type class 1 integron at the left-hand end, with the tni module located adjacent to the resolvase gene, carried the estX-qacE cassette array. The four genes of the transposition module [87% identity with Tn402 (X72585)] were a structural chimera [tniR, tniQ, tniB and tniA sharing, respectively, 100%, 99%, 100% and 95% identities with their homologues in Tn402, Tn5053 (L40585), Tn502 (EU306743) and Tn502, respectively]. The sul1-type class 1 integron (In5-type) at the right-hand end contained the aadB-aadA2 cassette array. Both integrons were in inverse orientation compared with their classical position in other genetic structures such as SGI1 or PGI1.
The mosaic structure between these two integrons was made of several parts of transposons and IS elements. It contained: (i) parts of transposons Tn1721, Tn5393 (strA-strB), Tn21 and the complete transposon Tn2 (bla TEM-1b ); and (ii) the following IS elements: IS1133 harboured by Tn5393, IS26, IS4321, which targeted the IR tnp end of Tn21 and IS1R inserted 58 bp from the IRmer of Genomic resistance island and ICE in Proteus mirabilis JAC Tn21 as in Tn2670. It is noteworthy that all components of this central region including the plasmid genes (topB and parB) have already been found in the MDR region of PGI1-PmCHA. 9 However, they are not in the same arrangement.
An extrachromosomal circular form of GIPmi1 was detected by a two-step PCR protocol, suggesting its potential mobility (primers used for PCRs are listed in Table S1 , available as Supplementary data at JAC Online, and the attG site in the circular form of GIPmi1 is represented in Figure S1 ). However, the conjugative transfer of GIPmi1 and its mobilization by an A/C plasmid failed despite three independent attempts to select gentamicin-resistant transconjugants. This result is not surprising because GIPmi1 does not carry tra genes.
Characterization of ICEPmiFra1
The ICEPmiFra1 of 104.2 kb belonging to the SXT/R391 family was inserted into the 5 0 end of prfC. Its backbone (72.7 kb) shared high sequence identity (99%) with that of ICEPmiChn1 recently described in China. 20 ICEPmiFra1 harboured floR and the sul2-strA-strB cluster in the variable region VRIII, as already described by Li et al. 18 ( Figure 2) . A composite transposon flanked by two copies of a transporter ISPpu12 element (tISPpu12) (AY128707) composed of four ORFs (a transposase and three passenger genes) was inserted in the hot spot HS4. The right-hand copy shared 99% identity with AY128707, but the left-hand one had a 2 nt deletion in tnpA leading to a shortened transposase (tISPpu12 isoform). An 8 bp target site duplication (TAAAGAAA) was detected, characteristic of a transposition event. This composite transposon carried a partial tetA(C)-tetR(C) mobile unit flanked by two copies of IS26, one of them being truncated by the tISPpu12 isoform, the transposon Tn4352 (aphA1a) and a sul1-type class 1 integron (dfrA32-ereA1-aadA2) with truncated 5 0 -CS (conserved sequence) and 3 0 -CS. Tn4352 might have been generated by incorporation at an existing IS26 of a translocatable unit made up of aphA1a and an IS26 as recently described. 21 The conjugative transfer of ICEPmiFra1 to E. coli K-12 C600 occurred at a frequency of 10 #8 chloramphenicol-resistant transconjugants per donor.
Conclusions
The MDR P. mirabilis PmPHI harboured two large GIs including a new ICE of the SXT/R391 family (ICEPmiFra1) and a new genomic resistance island (GIPmi1). GIPmi1 is the first member of a new lineage of genomic resistance island belonging to the superfamily of GIs proposed by Hamidian et al.
11 including SGI1, SGI2, PGI1 and AGI1. Indeed, it meets the criteria defining this superfamily: insertion at the 3 0 end of trmE and similar integrases. Nevertheless, the gene synteny was not conserved between GIPmi1 and SGI1/SGI2/ PGI1/AGI1 backbones. The presence of a resolvase gene within GIPmi1 allowed the integration of a class 1 integron. Multiple rearrangements involving fragments of known transposons and a IS26 element led to a very complex MDR region, which might easily incorporate genes conferring resistance to antibiotics of medical importance, as already described for SGI1 and PGI1.
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